Cargando…
Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms
Podoplanin (PDPN) is a unique transmembrane receptor that promotes tumor cell motility. Indeed, PDPN may serve as a chemotherapeutic target for primary and metastatic cancer cells, particularly oral squamous cell carcinoma (OSCC) cells that cause most oral cancers. Here, we studied how a monoclonal...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496201/ https://www.ncbi.nlm.nih.gov/pubmed/25826087 |
_version_ | 1782380367716548608 |
---|---|
author | Ochoa-Alvarez, Jhon A. Krishnan, Harini Pastorino, John G. Nevel, Evan Kephart, David Lee, Joseph J. Retzbach, Edward P. Shen, Yongquan Fatahzadeh, Mahnaz Baredes, Soly Kalyoussef, Evelyne Honma, Masaru Adelson, Martin E. Kaneko, Mika K. Kato, Yukinari Young, Mary Ann Deluca-Rapone, Lisa Shienbaum, Alan J. Yin, Kingsley Jensen, Lasse D. Goldberg, Gary S. |
author_facet | Ochoa-Alvarez, Jhon A. Krishnan, Harini Pastorino, John G. Nevel, Evan Kephart, David Lee, Joseph J. Retzbach, Edward P. Shen, Yongquan Fatahzadeh, Mahnaz Baredes, Soly Kalyoussef, Evelyne Honma, Masaru Adelson, Martin E. Kaneko, Mika K. Kato, Yukinari Young, Mary Ann Deluca-Rapone, Lisa Shienbaum, Alan J. Yin, Kingsley Jensen, Lasse D. Goldberg, Gary S. |
author_sort | Ochoa-Alvarez, Jhon A. |
collection | PubMed |
description | Podoplanin (PDPN) is a unique transmembrane receptor that promotes tumor cell motility. Indeed, PDPN may serve as a chemotherapeutic target for primary and metastatic cancer cells, particularly oral squamous cell carcinoma (OSCC) cells that cause most oral cancers. Here, we studied how a monoclonal antibody (NZ-1) and lectin (MASL) that target PDPN affect human OSCC cell motility and viability. Both reagents inhibited the migration of PDPN expressing OSCC cells at nanomolar concentrations before inhibiting cell viability at micromolar concentrations. In addition, both reagents induced mitochondrial membrane permeability transition to kill OSCC cells that express PDPN by caspase independent nonapoptotic necrosis. Furthermore, MASL displayed a surprisingly robust ability to target PDPN on OSCC cells within minutes of exposure, and significantly inhibited human OSCC dissemination in zebrafish embryos. Moreover, we report that human OSCC cells formed tumors that expressed PDPN in mice, and induced PDPN expression in infiltrating host murine cancer associated fibroblasts. Taken together, these data suggest that antibodies and lectins may be utilized to combat OSCC and other cancers that express PDPN. |
format | Online Article Text |
id | pubmed-4496201 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-44962012015-07-10 Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms Ochoa-Alvarez, Jhon A. Krishnan, Harini Pastorino, John G. Nevel, Evan Kephart, David Lee, Joseph J. Retzbach, Edward P. Shen, Yongquan Fatahzadeh, Mahnaz Baredes, Soly Kalyoussef, Evelyne Honma, Masaru Adelson, Martin E. Kaneko, Mika K. Kato, Yukinari Young, Mary Ann Deluca-Rapone, Lisa Shienbaum, Alan J. Yin, Kingsley Jensen, Lasse D. Goldberg, Gary S. Oncotarget Research Paper Podoplanin (PDPN) is a unique transmembrane receptor that promotes tumor cell motility. Indeed, PDPN may serve as a chemotherapeutic target for primary and metastatic cancer cells, particularly oral squamous cell carcinoma (OSCC) cells that cause most oral cancers. Here, we studied how a monoclonal antibody (NZ-1) and lectin (MASL) that target PDPN affect human OSCC cell motility and viability. Both reagents inhibited the migration of PDPN expressing OSCC cells at nanomolar concentrations before inhibiting cell viability at micromolar concentrations. In addition, both reagents induced mitochondrial membrane permeability transition to kill OSCC cells that express PDPN by caspase independent nonapoptotic necrosis. Furthermore, MASL displayed a surprisingly robust ability to target PDPN on OSCC cells within minutes of exposure, and significantly inhibited human OSCC dissemination in zebrafish embryos. Moreover, we report that human OSCC cells formed tumors that expressed PDPN in mice, and induced PDPN expression in infiltrating host murine cancer associated fibroblasts. Taken together, these data suggest that antibodies and lectins may be utilized to combat OSCC and other cancers that express PDPN. Impact Journals LLC 2015-03-10 /pmc/articles/PMC4496201/ /pubmed/25826087 Text en Copyright: © 2015 Ochoa-Alvarez et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Ochoa-Alvarez, Jhon A. Krishnan, Harini Pastorino, John G. Nevel, Evan Kephart, David Lee, Joseph J. Retzbach, Edward P. Shen, Yongquan Fatahzadeh, Mahnaz Baredes, Soly Kalyoussef, Evelyne Honma, Masaru Adelson, Martin E. Kaneko, Mika K. Kato, Yukinari Young, Mary Ann Deluca-Rapone, Lisa Shienbaum, Alan J. Yin, Kingsley Jensen, Lasse D. Goldberg, Gary S. Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms |
title | Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms |
title_full | Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms |
title_fullStr | Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms |
title_full_unstemmed | Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms |
title_short | Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms |
title_sort | antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496201/ https://www.ncbi.nlm.nih.gov/pubmed/25826087 |
work_keys_str_mv | AT ochoaalvarezjhona antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT krishnanharini antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT pastorinojohng antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT nevelevan antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT kephartdavid antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT leejosephj antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT retzbachedwardp antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT shenyongquan antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT fatahzadehmahnaz antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT baredessoly antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT kalyoussefevelyne antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT honmamasaru antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT adelsonmartine antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT kanekomikak antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT katoyukinari antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT youngmaryann antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT delucaraponelisa antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT shienbaumalanj antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT yinkingsley antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT jensenlassed antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms AT goldberggarys antibodyandlectintargetpodoplanintoinhibitoralsquamouscarcinomacellmigrationandviabilitybydistinctmechanisms |